| ACE-2 | Angiotensin-Converting Enzyme 2 |
| AF | Amniotic Fluid |
| AGE | Advanced Glycation End Product |
| AP-1 | Activator Protein 1 |
| ARDS | Acute Respiratory Distress Syndrome |
| c-RAGE | Cleaved Receptor Advanced Glycation End Products |
| DAMPs | Danger-Associated Molecular Patterns |
| DM | Diabetes Mellitus |
| ECM | Extracellular Matrix |
| EN-RAGE | Extracellular Newly Identified Receptor Advanced Glycation End Products Binding Protein (S100A12) |
| es-RAGE | Endogenous Soluble Receptor Advanced Glycation End Products |
| fl-RAGE | Full-Length Receptor Advanced Glycation End Products |
| FM | Fetal Membrane |
| GM-CSF | Granulocyte Macrophage Colony-Stimulating Factor |
| HMGB1 | High-Mobility Group Box Protein 1 |
| IL-6 | Interleukin 6 |
| MMP | Matrix Metalloproteinase |
| NF-κB | Nuclear Factor Kappa B |
| RAGE | Receptor Advanced Glycation End Products |
| ROS | Reactive Oxidative Species |
| s-RAGE | Secreted Receptor Advanced Glycation End Products |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| TNFα | Tumor Necrosis Factor Alpha |